Featured Research

from universities, journals, and other organizations

Research team discovers path to blocking fatal toxins

Date:
September 13, 2011
Source:
The Hebrew University of Jerusalem
Summary:
A team of researchers says it has found a way to block a group of fatal bacterial toxins that have to date resisted all attempts to arrest them through the use of conventional drugs.

A team of researchers at the Hebrew University of Jerusalem says it has found a way to block a group of fatal bacterial toxins that have to date resisted all attempts to arrest them through the use of conventional drugs.

These toxins, called superantigens, are produced by a group of "violent" staphylococcal and streptococcal bacteria. When these bacteria attack humans, they set off an extreme immune reaction described as an "immune storm," that is, an immune response of a magnitude higher in intensity than during a regular immune reaction. The result is often fatal toxic or septic shock brought on by the excessive immune response.

Working to develop the first effective antidote under funding from the Defense Advanced Research Projects Agency of the US Department of Defense and the US National Institutes of Health, the laboratory headed by Prof. Raymond Kaempfer of the Institute for Medical Research Israel Canada (IMRIC) at the Hebrew University Faculty of Medicine, has studied how superantigen toxins engage the immune system. The researchers discovered that in order to exert its harmful action, a superantigen must first bind to a protein on the surface of the human immune cell, a receptor called CD28.

CD28 has been known for a long time as a key participant in every immune response, but its ability to recognize microbial components -- the superantigens -- came as a complete surprise. The Kaempfer team discovered that superantigens do their lethal work by co-opting CD28 as their receptor, and that binding of a superantigen to CD28 is the key in the pathway to an immune storm.

They mapped the regions where the superantigen and CD28 contact each other and found that to induce an immune storm, superantigens must bind specifically into that part of the CD28 molecule where, normally, it pairs with another CD28 molecule.

Using that insight, they next designed decoys, short protein fragments that mimic the contact domain in the superantigen or in CD28. Such decoys, they could show, act as a monkey wrench that blocks the engagement of CD28 receptor by the superantigen toxin, thereby inhibiting the overly strong immune response and protecting animals from the toxic consequences, including from death.

All the superantigen toxins function via the same CD28 receptor, rendering the decoys broadly effective as protective agents. The decoys proved safe in healthy, normal, laboratory animals.

These findings provide a novel therapeutic approach against toxic shock. The decoys are host-oriented therapeutics, directed at the human immune system itself, rather than at the pathogen. Using a host-oriented therapeutic, resistance cannot arise in the infecting bacteria or in the toxins because the decoy targets a human immune receptor that is constant and will not change.

The work of Kaempfer and his team will be published in the journal PLoS Biology on Sept. 13. Reviewers who have seen an advanced copy have called the work "a surprising result with enormous implications" and "a paradigm shift in superantigen research."

The Kaempfer team involved senior researcher Dr. Gila Arad and graduate students Revital Levy, Iris Nasie, Ziv Rotfogel, Uri Barash, Emmanuelle Supper, Tomer Shpilka, and Adi Minis, with the support of lab technician Dalia Hillman.


Story Source:

The above story is based on materials provided by The Hebrew University of Jerusalem. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gila Arad, Revital Levy, Iris Nasie, Dalia Hillman, Ziv Rotfogel, Uri Barash, Emmanuelle Supper, Tomer Shpilka, Adi Minis, Raymond Kaempfer. Binding of Superantigen Toxins into the CD28 Homodimer Interface Is Essential for Induction of Cytokine Genes That Mediate Lethal Shock. PLoS Biology, 2011; 9 (9): e1001149 DOI: 10.1371/journal.pbio.1001149

Cite This Page:

The Hebrew University of Jerusalem. "Research team discovers path to blocking fatal toxins." ScienceDaily. ScienceDaily, 13 September 2011. <www.sciencedaily.com/releases/2011/09/110913172629.htm>.
The Hebrew University of Jerusalem. (2011, September 13). Research team discovers path to blocking fatal toxins. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2011/09/110913172629.htm
The Hebrew University of Jerusalem. "Research team discovers path to blocking fatal toxins." ScienceDaily. www.sciencedaily.com/releases/2011/09/110913172629.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins